|
Join the INTFG on LinkedIn!
The Inhalation and Nasal Technology Focus Group objectives are to:
- Foster and advance the art and science of the pharmaceutical inhalation aerosol
and nasal drug delivery system among focus group members and interested parties
- Provide and disseminate to its members information relating to matters of scientific
and technical interest in the field of inhalation aerosol and nasal drug delivery
products, aerosol and nasal technology, and related processes
- Encourage and undertake projects relating to matters of scientific and technical
interest in the field of inhalation aerosol and nasal drug delivery products, aerosol
and nasal technology, and related processes and, when appropriate, publish such
findings in the pharmaceutical press
- Support lateral discussion and exchange of ideas across different specialties in
the areas of novel drug delivery methods, delivery formulations, clinical trial
issues and regulatory sciences specific to inhalation and nasal drug delivery
- Foster and encourage a spirit of friendly cooperation among its members and to promote
favorable relations between its members and related health professionals
- Collect and disseminate, for the benefit of members and interested parties, such
information as may be deemed of value
- Organize seminars and/or symposiums in the general area of inhalation aerosol and
nasal drug products, aerosol and nasal drug delivery technology, and regulations
for inhalation and nasal drug products
UPCOMING EVENTS
Particle Engineering for Orally Inhaled Drug Products
2010 Inhalation and Nasal Technology Focus Group (INTFG) Fall Symposium
September 10, 2010
Hosted by: DPT Laboratories Ltd
Location: Hilton Gardens, Lakewood, NJ
Registration
The symposium includes lunch and is free of charge, but does require registration.
The one day workshop and poster session is limited to the first 100 registrants.
Registration Deadline: August 20, 2010
Hotel Reservations
A conference rate of $107.00 is available at the Hilton Garden in Lakewood for conference attendees checking in Thursday, September 9.
Call (732) 262-5232 or click here to book online - Be sure to enter TFG in the Group/Convention section when booking.
Poster Submissions
Poster submissions are currently being accepted and are open to all areas of inhalation/nasal research. The poster session will be limited to 20 posters.
Deadline for Submissions: August 20, 2010
Topics: Papers must be related to inhalation and or nasal drug delivery development or testing.
Length of submission: Abstract must fit on one page of 8-1/2" X 11" paper.
Type of document: MS Word or pdf
Submit abstracts to:
Mr. William J. Schachtner
PPD, Middleton, WI, United States
For questions or more information, please contact the symposium Co-Chairs:
Jason Ehrick
Sai Chamarthy
ISAM/IPAC-RS European Bioequivalence Workshop on European Bioequivalence Considerations for Orally Inhaled Products for Local Action
Frankfurt, Germany
October 12-13, 2010
FIP Pharmaceutical Sciences World Congress 2010 in association with the AAPS Annual Meeting & Exposition
November 14-18, 2010
Morial Convention Center, New Orleans, Louisiana, USA
Back To Top
Inhalation Inspiration – The AAPS Inhalation and Nasal Technology
Focus Group Newsletter
Back To Top
INTFG Past Events
Respiratory Drug Delivery 2010 INTFG Evening Program
April 27, 2010
Orlando, FL
Imaging in Pulmonary and Nasal Product Development - Not Just Pretty Pictures
Presented by Stephen P. Newman, Ph.D., Scientific Consultant, U.K.
Event Pictures
Pharmacokinetic-pharmacodynamic Aspects of Inhaled Lung-targeted Agents
November 11, 2009
2009 AAPS Annual Meeting and Exposition, Los Angeles, CA
AAPS Inhalation and Nasal Technology Focus Group Meeting: Nanotechnology and Relevance to Inhalation/Nasal Drug Delivery
September 18, 2009 Schering-Plough Research Institute
Summit, NJ
2009 Fall Symposium Pictures
Next Generation Nano Carriers for Multifunctional Drug Delivery, Imaging, and Targeting- Application to Composite Aerosol Drug Delivery?
Robert Prud'homme, Ph.D., Princeton University
Translocation of Inhaled Ultrafine Manganese Oxide Particles to the Central Nervous System
Alison Elder, Ph.D., University of Rochester
FDA Considerations for Nanomaterial-Containing Products
Nakissa Sadrieh, Ph.D., Food and Drug Administration
Nanosuspensions for Inhalation Therapy: Drug/Stabilizer Interactions
Diane J. Burgess, Ph.D., University of Connecticut
Intranasal Delivery of Drugs to the Brain
Shyeilla V. Dhuria, Ph.D., Novartis Pharmaceuticals Corporation
Challenges in Developing Inhalation and Nasal Products: Linking to Quality by Design
November 18, 2008
2008 AAPS Annual Meeting and Exposition, Atlanta, GA
Inhalation Devices - Recent Advances in Technology and Regulation
September 19, 2008
2008 Inhalation and Nasal Technology Focus Group Fall Symposium, Ridgefield, CT
Inhaled Drugs and Vaccines for Infectious Diseases in Low-Income Settings
presented by David Edwards
May 13, 2008
Respiratory Drug Delivery 2008, Scottsdale, AZ
Back To Top
JOIN THE INHALATION AND NASAL TECHNOLOGY FOCUS GROUP
To join the Inhalation and Nasal Technology Focus Group, click
here.
Back To Top
|
